Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Wilarat Puangmanee"'
Autor:
Rochanawan Sootichote, Wilarat Puangmanee, Surachet Benjathummarak, Siriporn Kowaboot, Atsushi Yamanaka, Korbporn Boonnak, Sumate Ampawong, Supawat Chatchen, Pongrama Ramasoota, Pannamthip Pitaksajjakul
Publikováno v:
Biomedicines, Vol 11, Iss 1, p 227 (2023)
Due to the lack of an effective therapeutic treatment to flavivirus, dengue virus (DENV) nonstructural protein 1 (NS1) has been considered to develop a vaccine owing to its lack of a role in antibody-dependent enhancement (ADE). However, both NS1 and
Externí odkaz:
https://doaj.org/article/e7afe4f7d3e34d6bb0b290d47ccb5aa7
Autor:
Subenya Injampa, Surachet Benjathummarak, Sujitra Keadsanti, Wilarat Puangmanee, Atsushi Yamanaka, Tadahiro Sasaki, Kazuyoshi Ikuta, Pongrama Ramasoota, Pannamthip Pitaksajjakul
Background Dengue disease is a mosquito-borne infection caused by four dengue virus serotypes (DENV1-4). Secondary infections can produce flavivirus cross-reactive antibodies at sub-neutralizing levels. This phenomenon can significantly increase the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5f8933fc5eee59af8e48a33c2893fe3
https://doi.org/10.1101/2023.05.25.542225
https://doi.org/10.1101/2023.05.25.542225
Autor:
Pongrama Ramasoota, Surachet Benjathummarak, Siriporn Kowaboot, Pannamthip Pitaksajjakul, Khwanchit Boonha, Wilarat Puangmanee, Urai Chaisri
Publikováno v:
Japanese Journal of Infectious Diseases. 75:24-30
Mouse antibodies specific to dengue NS1 have been widely investigated for their cross-reactivity with several human biomolecules. This is the first study demonstrating the cross-reactivity of human monoclonal antibodies (HuMAbs) specific to dengue NS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4896f5f1cb66d9807ff0e116b63e5afc
https://doi.org/10.7883/yoken.jjid.2020.1071
https://doi.org/10.7883/yoken.jjid.2020.1071
Autor:
Pannamthip Pitaksajjakul, Subenya Injampa, Nipa Thammasonthijarern, Chonlatip Pipattanaboon, Pongrama Ramasoota, Wilarat Puangmanee, Pimolpachr Sriburin, Supawat Chatchen, Weerapong Phumirattanaprapin
Publikováno v:
Japanese journal of infectious diseases. 73(2)
Dengue is one of the most serious mosquito-borne viral diseases occurring in humans. To combat the complexity of 4 antigenically distinct serotypes, the ideal vaccine for dengue should be able to stimulate cross-neutralizing antibodies. Recently, gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffbfc55349a9300fb67cb4c3f8d4df7b
https://pubmed.ncbi.nlm.nih.gov/31787738
https://pubmed.ncbi.nlm.nih.gov/31787738